PeDRA Pearls
Un pódcast de Pediatric Dermatology Research Alliance
222 Episodo
-
Publication Presentation: Care of Congenital Melanocytic Nevi in Newborns and Infants
Publicado: 28/6/2022 -
Getting to Know You: Jillian Rork, MD
Publicado: 16/6/2022 -
PeDRA at 2022 Society for Investigative Dermatology
Publicado: 2/6/2022 -
Hidradenitis Suppurativa Points of Discussion - Episode 3: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?
Publicado: 27/5/2022 -
Hidradenitis Suppurativa Points of Discussion - Episode 2: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?
Publicado: 27/5/2022 -
Hidradenitis Suppurativa Points of Discussion - Episode 1: Should Pediatric Hidradenitis Suppurativa be Treated Aggressively?
Publicado: 27/5/2022 -
Getting to Know You: Carrie Coughlin, MD, MPHS
Publicado: 18/5/2022 -
Getting to Know You: PeDRA
Publicado: 22/4/2022 -
Down Syndrome Points of Discussion - Episode 3: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?
Publicado: 6/4/2022 -
Down Syndrome Points of Discussion - Episode 2: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?
Publicado: 6/4/2022 -
Down Syndrome Subgroup Points of Discussion - Episode 1: Should Immune Modulators be Prescribed for Skin Diseases in Children with Down Syndrome?
Publicado: 6/4/2022 -
Getting to Know You: Harper Price, MD
Publicado: 18/3/2022 -
Early Investigator Webinar: Imposter No More
Publicado: 3/3/2022 -
New Advances in the Treatment of Atopic Dermatitis in Children
Publicado: 2/3/2022 -
Getting to Know You: Megha Tollefson, MD
Publicado: 16/2/2022 -
Atopic Dermatitis Points of Discussion - Episode 3: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?
Publicado: 31/1/2022 -
Atopic Dermatitis Points of Discussion - Episode 2: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?
Publicado: 31/1/2022 -
Atopic Dermatitis Points of Discussion - Episode 1: Should JAK Inhibitors be Considered for First-Line Therapy in the Treatment of AD in Children?
Publicado: 31/1/2022 -
Getting to Know You: Beth Drolet, MD
Publicado: 19/1/2022 -
Neonatal Skin Points of Discussion- Episode 3: Is Sunscreen Use Safe in Infants under 6 Months?
Publicado: 30/12/2021
The Pediatric Dermatology Research Alliance (PeDRA) is vibrant research network pursuing the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.
